Nuveen Fund Advisors’s GSK GSK Stock Holding History

Nuveen Fund Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,562	Closed	-$409K	–	14
2018 Q4	$409K	Sell	8,562 -10,924	-56%	-$538K	3.63%	6
2018 Q3	$978K	Sell	19,486 -8,036	-29%	-$408K	2.17%	5
2018 Q2	$1.39M	Sell	27,522 -10,204	-27%	-$514K	1.71%	5
2018 Q1	$1.84M	Sell	37,726 -5,644	-13%	-$263K	0.85%	32
2017 Q4	$1.92M	Sell	43,370 -6,820	-14%	-$315K	0.56%	45
2017 Q3	$2.55M	Sell	50,190 -5,175	-9%	-$263K	0.52%	50
2017 Q2	$2.92M	Sell	55,365 -1,067	-2%	-$56.9K	0.47%	59
2017 Q1	$2.95M	Buy	56,432 +13,082	+30%	+$664K	0.39%	88
2016 Q4	$2.09M	Buy	43,350 +11,753	+37%	+$581K	0.3%	115
2016 Q3	$1.7M	Buy	31,597 +3,991	+14%	+$219K	0.24%	142
2016 Q2	$1.5M	Buy	+27,606	New	+$1.45M	0.23%	126

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Nuveen Fund Advisors's GSK Position: Q1 2019 in Review

Nuveen Fund Advisors sold out of GSK (GSK) in Q1 2019, closing a stake of 8,562 shares — an estimated $409K sold.

Nuveen Fund Advisors first reported a position in GSK in Q2 2016 and held it in 11 quarters. The position peaked at $2.95M in Q1 2017. 847 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

Nuveen Fund Advisors reported no remaining GSK position as of Q1 2019 after selling out during the quarter.
Nuveen Fund Advisors sold 8,562 GSK shares in Q1 2019, an estimated $409K.
Nuveen Fund Advisors first reported a position in GSK in Q2 2016 and held it in 11 quarters.
Nuveen Fund Advisors's GSK position peaked at $2.95M in Q1 2017.
847 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on Nuveen Fund Advisors's 13F filing for Q1 2019, filed 14 May 2019.